CRNX 240621 55.00C (CRNX240621C55000) Stock Options, News & Quotes

US OptionsDetailed Quotes

CRNX240621C55000

Watchlist

0.10
-0.05-33.33%

15min DelayClose Jun 14 15:43 ET

0.10High0.10Low

Intraday

News

Insider Sale at Crinetics Pharmaceuticals Inc (CRNX): Chief Scientific Officer Stephen Betz ...
Yahoo FinanceJun 12 02:38 ET
Crinetics(CRNX.US) Officer Sells US$131.58K in Common Stock
$Crinetics(CRNX.US)$ Officer Betz Stephen F. sold 3,000 shares of common stock on Jun 10, 2024 at an average price of $43.86 for a total value of $131.58K.Source: Announcement What is statement of cha
moomoo NewsJun 11 17:17 ET
Express News | Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersJun 10 18:35 ET
Form 144 | Crinetics(CRNX.US) Officer Proposes to Sell 131.58K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 10, $Crinetics(CRNX.US)$ Officer Betz Stephen F. intends to sell 3,000 shares of its common stock on Jun 10, with a total market value of approximately $131.58K. Betz Ste
moomoo NewsJun 10 11:59 ET
A Quick Look at Today's Ratings for Crinetics(CRNX.US), With a Forecast Between $60 to $80
On Jun 04, major Wall Street analysts update their ratings for $Crinetics(CRNX.US)$, with price targets ranging from $60 to $80.Morgan Stanley analyst Jeffrey Hung maintains with a buy rating, and mai
moomoo NewsJun 4 09:00 ET
Express News | Crinetics Pharmaceuticals : Oppenheimer Raises Target Price to $74 From $55
ReutersJun 4 08:25 ET

Comments

Meltyy

May 22 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics(IOVA.US)$ Phase 2
$Supernus Pharmaceuticals(SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US)$ Phase 2a
$MorphoSys(MOR.US)$ Phase 2
$Nuvation Bio(NUVB.US)$ Phase 2
$ALX Oncology(ALXO.US)$ Phase 2
$BioXcel Therapeutics(BTAI.US)$ Phase 2
$Purple Biotech(PPBT.US)$ Phase 2
$Arcus Biosciences(RCUS.US)$ Phase 2
$Medicenna Therapeutics(MDNAF.US)$ Phase 2b
$Affimed NV(AFMD.US)$ Phase 2
$Barinthus Biotherapeutics(BRNS.US)$ Phase 2b...

Meltyy

May 12 21:23

🎯 Ph 3 readouts in Q2 2024...

$United Therapeutics(UTHR.US)$ Phase 3
$Ironwood Pharmaceuticals(IRWD.US)$ Phase 3
$Liquidia(LQDA.US)$ Phase 3
$United Therapeutics(UTHR.US)$ Phase 3
$MorphoSys(MOR.US)$ Phase 3
$Immunocore(IMCR.US)$ Phase 3
$Crinetics(CRNX.US)$ Phase 3
$UroGen Pharma Ltd(URGN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$Capricor Therapeutics(CAPR.US)$ Phase 3
$Annexon(ANNX.US)$ Phase 3
$Lipocine(LPCN.US)$ Phase 3...

Meltyy

Mar 4 03:54

🎯 Ph 3 readouts in Q1 2024...

$Pfizer(PFE.US)$ Phase 3
$BioCardia(BCDA.US)$ Phase 3
$Atea Pharmaceuticals(AVIR.US)$ Phase 3
$Crinetics(CRNX.US)$ Phase 3
$Axsome Therapeutics(AXSM.US)$ Phase 3
$ROCHE HOLDING AG(RHHBY.US)$ Phase 3
$ACADIA Pharmaceuticals(ACAD.US)$ Phase 3
$Sellas Life Sciences(SLS.US)$ Phase 3
$Aquestive Therapeutics(AQST.US)$ Phase 3
$Jaguar Health(JAGX.US)$ Phase 3
$Novocure(NVCR.US)$ Phase 3
$Johnson & Johnson(JNJ.US)$ Phase 3

LuckyLuke

Feb 29 04:24

$Crinetics (CRNX.US)$ Overvalued 80%

Meltyy

Feb 26 00:34

4 Bio Readouts To Watch This Qtr

1. $Annovis Bio(ANVS.US)$
• Ph 3 data (also Ph 2/3 in AD).
• Buntanetap for Parkinson’s Disease.
• Exp Jan '24 but delayed (est this qtr).
2. $Axsome Therapeutics(AXSM.US)$
• Ph 3 data (SYMPHONY).
• AXS-12 for Narcolepsy.
• AXS-12 has Orphan Drug Designation.
3. $G1 Therapeutics(GTHX.US)$
• Ph 3 Overall Survival (OS) data.
• Trilaciclib (combo) for breast cancer (mTNBC).
• DMC recommended continuation earlier in Feb.
4. $Crinetics(CRNX.US)$
• Ph 3 data (PATHFND...